1. Patent Issued for Transdermal drug delivery devices and methods (USPTO 12042614)
- Subjects
Disodium pamidronate -- Methods -- Intellectual property ,Nabilone -- Methods ,Trimipramine -- Methods -- Intellectual property ,Tirofiban -- Intellectual property -- Methods ,Antidepressants -- Methods -- Intellectual property ,Amoxapine -- Intellectual property -- Methods ,Lorcaserin -- Methods ,Tiotropium -- Intellectual property -- Methods ,Physical fitness -- Methods ,Opioids -- Methods ,Hypnotics -- Methods -- Intellectual property ,Sedatives -- Methods -- Intellectual property ,Antiparkinsonian agents -- Methods ,Dopamine -- Agonists ,Oxaprozin -- Methods -- Intellectual property ,Bupivacaine -- Intellectual property -- Methods ,Asenapine -- Methods ,Transdermal medication -- Intellectual property -- Methods ,Anticonvulsants -- Intellectual property -- Methods ,Acamprosate -- Methods -- Intellectual property ,Dolasetron -- Methods -- Intellectual property ,Loxapine -- Methods ,Clopidogrel -- Methods -- Intellectual property ,Zileuton -- Methods -- Intellectual property ,Armodafinil -- Methods ,Health - Abstract
2024 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Morningside Venture Investments Limited (Monaco, Monaco) has been issued patent number 12042614, [...]
- Published
- 2024